1-4 of 4
Ben Samelson-Jones
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel Murine Model Rebalancing Coagulation Enables Gene Therapy Studies for Severe Protein C Deficiency, a Lethal Pro-Thrombotic Disorder

Sarina Levy-Mendelovich, Einat Avishai, Ben Samelson-Jones, Rima Dardik, Tami barazani-Brutman, Yael Nisgav, Tami Livnat, Gili Kenet
Journal: Blood
Blood (2024) 144 (Supplement 1): 430.
https://doi.org/10.1182/blood-2024-199955
Published: 2024
Journal Articles

Success of Immune Tolerance Induction after AAV Gene Therapy in High-Responding Inhibitor Hemophilia a Dogs May be F8 Genotype Dependent

Yani B Suber, Bhavya S Doshi, Robert A French, Elizabeth Merricks, Timothy Nichols, Ben Samelson-Jones
Journal: Blood
Blood (2024) 144 (Supplement 1): 3579.
https://doi.org/10.1182/blood-2024-199820
Published: 2024
Journal Articles

Use of Fidanacogene Elaparvovec, a Gene Therapy Vector, to Deliver a Stable, Fully Functional Human Factor IX Transgene for the Treatment of Hemophilia B: A Combined Analysis of Safety

Ben Samelson-Jones, Laurent Frenzel, Kaan Kavakli, Adam Cuker, Jerome M. Teitel, Pengling Sun, Lisa J Wilcox, Francesca Biondo, Benjamin Hutter, John McKay, Delphine Agathon, Frank Plonski
Journal: Blood
Blood (2024) 144 (Supplement 1): 3577.
https://doi.org/10.1182/blood-2024-193453
Published: 2024
Journal Articles

Warfarin Exposure Leads to Loss of Binding of Emicizumab to Factor IX

Kerry W Lannert, Ben Samelson-Jones, Katarina Berk, Nicholas A Popp, John P. Sheehan, Doug M Fowler, Jill M Johnsen
Journal: Blood
Blood (2024) 144 (Supplement 1): 3955.
https://doi.org/10.1182/blood-2024-211847
Published: 2024